Literature DB >> 30316463

Whole-Body Magnetic Resonance Imaging in Oncology: Uses and Indications.

Giuseppe Petralia1, Anwar R Padhani2.   

Abstract

Whole-body MRI (WB-MRI) has emerged as a radiation-free method for the diagnosis, staging, and therapy response assessments in cancer patients. This article reviews the current roles for WB-MRI in the clinical context of limitations of currently used techniques, focusing on bone marrow disease applications. Indication for broader clinical use are discussed, including guideline recommendations. The emerging screening role of WB-MRI in subjects at high risk of cancer is discussed, as is normal population screening.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone marrow disease; Breast cancer; Lymphoma; Melanoma; Multiple myeloma; Prostate cancer; Response assessment; Whole-body-MR Imaging

Mesh：

Year:  2018        PMID： 30316463     DOI： 10.1016/j.mric.2018.06.003

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN： 1064-9689            Impact factor:   2.266


  8 in total

Review 1.  The Dixon technique for MRI of the bone marrow.

Authors:  Niels van Vucht; Rodney Santiago; Bianca Lottmann; Ian Pressney; Dorothee Harder; Adnan Sheikh; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2019-07-15       Impact factor: 2.199

2.  Preliminary observations regarding the expectations, acceptability and satisfaction of whole-body MRI in self-referring asymptomatic subjects.

Authors:  Derna Busacchio; Ketti Mazzocco; Sara Gandini; Paola Pricolo; Marianna Masiero; Paul Eugene Summers; Grabriella Pravettoni; Giuseppe Petralia
Journal:  Br J Radiol       Date:  2020-12-01       Impact factor: 3.039

3.  Semi-Automated Segmentation of Bone Metastases from Whole-Body MRI: Reproducibility of Apparent Diffusion Coefficient Measurements.

Authors:  Alberto Colombo; Giulia Saia; Alcide A Azzena; Alice Rossi; Fabio Zugni; Paola Pricolo; Paul E Summers; Giulia Marvaso; Robert Grimm; Massimo Bellomi; Barbara A Jereczek-Fossa; Anwar R Padhani; Giuseppe Petralia
Journal:  Diagnostics (Basel)       Date:  2021-03-11

4.  Value Attribution in the Decision to Use of Whole Body MRI for Early Cancer Diagnosis.

Authors:  Derna Busacchio; Ketti Mazzocco; Davide Radice; Paul E Summers; Paola Pricolo; Gabriella Pravettoni; Giuseppe Petralia
Journal:  Diagnostics (Basel)       Date:  2021-05-28

Review 5.  Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations.

Authors:  Fabio Zugni; Anwar Roshanali Padhani; Dow-Mu Koh; Paul Eugene Summers; Massimo Bellomi; Giuseppe Petralia
Journal:  Cancer Imaging       Date:  2020-05-11       Impact factor: 3.909

6.  Multiple comparison correction methods for whole-body magnetic resonance imaging.

Authors:  Eva Breznik; Filip Malmberg; Joel Kullberg; Håkan Ahlström; Robin Strand
Journal:  J Med Imaging (Bellingham)       Date:  2020-02-28

7.  Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels.

Authors:  Paola Pricolo; Eleonora Ancona; Paul Summers; Jorge Abreu-Gomez; Sarah Alessi; Barbara Alicja Jereczek-Fossa; Ottavio De Cobelli; Franco Nolè; Giuseppe Renne; Massimo Bellomi; Anwar Roshanali Padhani; Giuseppe Petralia
Journal:  Cancer Imaging       Date:  2020-10-27       Impact factor: 3.909

Review 8.  Whole-body magnetic resonance imaging (WB-MRI) for cancer screening: recommendations for use.

Authors:  Giuseppe Petralia; Fabio Zugni; Paul E Summers; Alberto Colombo; Paola Pricolo; Luigi Grazioli; Stefano Colagrande; Andrea Giovagnoni; Anwar R Padhani
Journal:  Radiol Med       Date:  2021-08-02       Impact factor: 3.469
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.